期刊文献+

新型神经营养因子CDNF/MANF家族与帕金森病 被引量:3

原文传递
导出
摘要 帕金森病作为一种运动障碍性疾病,其治疗方法一直处在探索阶段,而目前的治疗方法只能缓解其症状并不能阻止疾病的进行和发展。神经营养因子是一种对神经元有保护作用的营养因子,在其近年新发现的新型神经营养因子-CDNF/MANF家族因具有良好的神经保护和神经修复作用将成为研究的热点,本文就CDNF/MANF家族与治疗帕金森病的研究作一篇综述。
作者 韩暄 牛朝诗
出处 《立体定向和功能性神经外科杂志》 2011年第5期313-316,共4页 Chinese Journal of Stereotactic and Functional Neurosurgery
基金 国家自然科学基金项目(编号:81100960) 安徽省自然科学基金项目(编号:11040606Q11)
  • 相关文献

参考文献20

  • 1Airaksinen MS, Saarma M. The GDNF family: Signal- ling, biological functions and therapeutic value[J]. Nat Rev Neurosci, 2002, 3 (5): 383~394.
  • 2Chauhan NB, Siegel GJ, Lee JM. Depletion of glial cell line--derived neurotrophic factor in substantia nigra neu-rons of Parkinson's disease brain[J]. J Chem Neuroanat, 2001, 21(4) :277~288.
  • 3Gill SS, Patel NK, Hotton GR, et al. Direct brain infu- sion of glial cell line--derived neurotrophic factor in Par- kinson disease [J]. Nat Med, 2003,9(5):589~595.
  • 4Lang AE, Gill S, Patel NK, et al. Randomized con- trolled trial of intraputamenal glial cell line--derived neu- rotrophic factor infusion in Parkinson disease[J]. Ann Neurol, 2006,59(3) .459~466.
  • 5Slevin JT, Gerhardt GA, Smith CD, et al. Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line--derived neurotrophie factor[J]. J Neuro- surg, 2005 , 102 (2) : 216~222.
  • 6MarksWJ Jr, Ostrem JL, Verhagen L, et al. Safety and tolerability of intraputaminal delivery of CERE- 120 (adenoassociated virus serotype 2--neurturin) to patients with idiopathic Parkinson's disease: an open- label, phase I trial[J]. Lancet Neurol, 2008,7(5) : 400~408.
  • 7Hamilton JF,Morrison PF,ChenMY,et al. Heparin coin- fusion during convection--enhanced delivery (CED) in- creases the distribution of the glial--derived neurotrophic factor (GDNF) ligand family in rat striatum and en- hances the pharmacological activity of neurturin[J]. Exp Neurol, 2001,168(1) : 155~161.
  • 8Salvatore MF, Ai Y, Fischer B, et al. Point source con- centration of GDNFmay explain failure of phase II clinical trial[J]. Exp Neurol, 2006,202 (2) : 497~505.
  • 9Lindholm P, Voutilainen MH, Lauren J, et al. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo[J]. Nature, 2007. 448 (7149) 73~77.
  • 10Voutilainen, MH, tNck, S, Porsti, E, et al. Mesence- phalic astrocyte--derived neurotrophic factor is neuro- restorative in rat model of Parkinson's disease[J]. J Neurosci, 2009,29(30) : 9651~9659.

同被引文献49

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部